{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:45:25Z","timestamp":1761871525923,"version":"build-2065373602"},"reference-count":55,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.clml.2021.03.004","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T20:17:46Z","timestamp":1616271466000},"page":"e635-e643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Types, Clinical Features, and Survival Outcomes of Patients with Acute Myeloid Leukemia in Thailand: A 3-Year Prospective Multicenter Study from the Thai Acute Leukemia Study Group (TALSG)"],"prefix":"10.1016","volume":"21","author":[{"given":"Chinadol","family":"Wanitpongpun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eakkapol","family":"Utchariyaprasit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weerapat","family":"Owattanapanich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adisak","family":"Tantiworawit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekarat","family":"Rattarittamrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pimjai","family":"Niparuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teeraya","family":"Puavilai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakrawadee","family":"Julamanee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pirun","family":"Saelue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantiya","family":"Chanswangphuwana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantana","family":"Polprasert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chajchawan","family":"Nakhakes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wasithep","family":"Limvorapitak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nonglak","family":"Kanitsap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kannadit","family":"Prayongratana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantrapa","family":"Sriswasdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"67","key":"10.1016\/j.clml.2021.03.004_bib0001","first-page":"7","article-title":"Cancer Statistics, 2017","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clml.2021.03.004_bib0002","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"18","article-title":"Introduction and overview of classification of the myeloid neoplasms","author":"Vardiman","year":"2008"},{"key":"10.1016\/j.clml.2021.03.004_bib0003","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1182\/blood-2008-07-172007","article-title":"Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry","volume":"113","author":"Juliusson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.03.004_bib0004","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"110","article-title":"Acute myeloid leukemia with recurrent genetic abnormalities","author":"Arber","year":"2008"},{"key":"10.1016\/j.clml.2021.03.004_bib0005","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"130","article-title":"Acute myeloid leukeia, not otherwise specified","author":"Arber","year":"2008"},{"key":"10.1016\/j.clml.2021.03.004_bib0006","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","article-title":"Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet","volume":"115","author":"D\u00f6hner","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.03.004_bib0007","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.7314\/APJCP.2015.16.14.5945","article-title":"Incidence, risk factors, and outcomes of febrile neutropenia in Thai hematologic malignancy patients receiving chemotherapy: a 6-year retrospective cohort study","volume":"16","author":"Limvorapitak","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.clml.2021.03.004_bib0008","first-page":"1143","article-title":"Long-term outcomes of de novo acute myeloid leukemia in Thai patients","volume":"92","author":"Niparuck","year":"2009","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.clml.2021.03.004_bib0009","first-page":"140","article-title":"Costs and treatment outcomes of patients with acute leukemia in Suppasittiprasong Hospital, Ubonratchathani","volume":"2","author":"Kanjanawat","year":"2009","journal-title":"Isarn J Pharm Sci"},{"key":"10.1016\/j.clml.2021.03.004_bib0010","first-page":"2565","article-title":"Cost analysis of hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia at King Chulalongkorn Memorial Hospital","volume":"90","author":"Ngamkiatphaisan","year":"2007","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.clml.2021.03.004_bib0011","unstructured":"Cancer.net. Leukemia - Acute Myeloid -AML: statistics. Available at: https:\/\/www.cancer.net\/cancer-types\/leukemia-acute-myeloid-aml\/statistics. Accessed: March 11, 2021."},{"key":"10.1016\/j.clml.2021.03.004_bib0012","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1182\/blood-2011-12-379008","article-title":"Acute myeloid leukemia in the real world: why population-based registries are needed","volume":"119","author":"Juliusson","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.03.004_bib0013","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12185-012-1150-6","article-title":"Clinical studies of acute myeloid leukemia in the Japan Adult Leukemia Study Group","volume":"96","author":"Miyawaki","year":"2012","journal-title":"Int J Hematol"},{"key":"10.1016\/j.clml.2021.03.004_bib0014","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2003.04.036","article-title":"Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia","volume":"21","author":"Cheson","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2021.03.004_bib0015","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"124","article-title":"Acute myeloid leukemia with myelodysplasia-related changes","author":"Arber","year":"2008"},{"key":"10.1016\/j.clml.2021.03.004_bib0016","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"130","article-title":"Myeloid sarcoma","author":"Pileri","year":"2008"},{"key":"10.1016\/j.clml.2021.03.004_bib0017","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"127","article-title":"Therapy-related myeloid neoplasms","author":"Vardiman","year":"2008"},{"key":"10.1016\/j.clml.2021.03.004_bib0018","first-page":"153","article-title":"Immunophenotypic profile of adult acute myeloid leukemia (AML): analysis of 267 cases in Thailand","volume":"21","author":"Auewarakul","year":"2003","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.clml.2021.03.004_bib0019","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/bjh.12750","article-title":"Prognostic factors for acute myeloid leukaemia in adults\u2013biological significance and clinical use","volume":"165","author":"Liersch","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2021.03.004_bib0020","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","article-title":"The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties","volume":"92","author":"Grimwade","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.03.004_bib0021","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1182\/asheducation-2009.1.385","article-title":"Independent prognostic factors for AML outcome","volume":"1","author":"Grimwade","year":"2009","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.clml.2021.03.004_bib0022","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.5858\/arpa.2015-0203-RA","article-title":"Acute myeloid leukemia genetics: risk stratification and implications for therapy","volume":"139","author":"Wang","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.clml.2021.03.004_bib0023","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/ajh.23404","article-title":"Acute myeloid leukemia: 2013 update on risk-stratification and management","volume":"88","author":"Estey","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2021.03.004_bib0024","first-page":"1530","article-title":"The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia","volume":"91","author":"Webert","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2021.03.004_bib0025","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4103\/1658-5127.186326","article-title":"A case series of patients with de novo Philadelphia-positive acute myeloid leukemia at a tertiary care center in South India - clinical profile, outcomes, and review of literature","volume":"7","author":"Loknatha","year":"2016","journal-title":"J Appl Hematol"},{"key":"10.1016\/j.clml.2021.03.004_bib0026","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12288-016-0640-8","article-title":"De novo Philadelphia positive acute myeloid leukemia with extensive basophilia: a diagnostic dilemma","volume":"32","author":"Singh","year":"2016","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.clml.2021.03.004_bib0027","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1309\/B4NVER1AJJ84CTUU","article-title":"Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis","volume":"127","author":"Soupir","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2021.03.004_bib0028","doi-asserted-by":"crossref","first-page":"S296","DOI":"10.1016\/j.clml.2017.07.088","article-title":"Survival impact of tyrosine kinase inhibitors (TKIs) in Philadelphia chromosome positive (Ph+) de novo acute myeloid leukemia (AML)","volume":"17","author":"Chan","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2021.03.004_bib0029","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s12185-009-0483-2","article-title":"Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia: results of the JALSG AML97 study","volume":"91","author":"Sakamaki","year":"2010","journal-title":"Int J Hematol"},{"key":"10.1016\/j.clml.2021.03.004_bib0030","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1080\/10428190701836852","article-title":"Therapeutic experience of adult acute myeloid leukemia in a single institution of China and its relationship with chromosome karyotype","volume":"49","author":"Mi","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2021.03.004_bib0031","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1445-5994.1999.tb01622.x","article-title":"Treatment of de novo acute myeloid leukaemia in Hong Kong: a twenty-year experience (1975 to 1996)","volume":"29","author":"Chim","year":"1999","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.clml.2021.03.004_bib0032","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1177\/147323000903700426","article-title":"World Health Organization sub-types, initial treatment outcome and prognostic study of unselected adult patients with acute myeloid leukaemia in Shanghai: an analysis of 623 cases","volume":"37","author":"Ma","year":"2009","journal-title":"J Int Med Res"},{"key":"10.1016\/j.clml.2021.03.004_bib0033","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/bjh.13406","article-title":"Acute myeloid leukaemia: challenges and real world data from India","volume":"170","author":"Philip","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2021.03.004_bib0034","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1200\/JCO.2010.33.7212","article-title":"Long-term survival and late deaths after allogeneic hematopoietic cell transplantation","volume":"29","author":"Wingard","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2021.03.004_bib0035","first-page":"265","article-title":"Treatment of adult acute myelogenous leukemia: a pilot study at Chulalongkorn Hospital","volume":"74","author":"Intragumtornchai","year":"1991","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.clml.2021.03.004_bib0036","first-page":"12","article-title":"Outcome of acute myeloid leukaemia in adults: a retrospective analysis","volume":"18","author":"Saikia","year":"2005","journal-title":"Natl Med J India"},{"key":"10.1016\/j.clml.2021.03.004_bib0037","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.clml.2018.02.002","article-title":"Outcomes of adolescents and young adults with acute myeloid leukemia treated in a single Latin American center","volume":"18","author":"Jaime-P\u00e9rez","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2021.03.004_bib0038","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/ajh.10270","article-title":"Ethnicity and prognosis in acute myeloid leukemia","volume":"72","author":"Alcalai","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2021.03.004_bib0039","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12185-013-1373-1","article-title":"Survival and prognostic factors in Malaysian acute myeloid leukemia patients after allogeneic haematopoietic stem cell transplantation","volume":"98","author":"Mangantig","year":"2013","journal-title":"Int J Hematol"},{"key":"10.1016\/j.clml.2021.03.004_bib0040","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1038\/bcj.2016.50","article-title":"Acute myeloid leukemia: a comprehensive review and 2016 update","volume":"6","author":"De Kouchkovsky","year":"2016","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.clml.2021.03.004_bib0041","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.7314\/APJCP.2016.17.3.1547","article-title":"Prognostic factors and survival in acute myeloid leukemia cases: a report from the northeast of Iran","volume":"17","author":"Allahyari","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.clml.2021.03.004_bib0042","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s12185-008-0025-3","article-title":"Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol","volume":"87","author":"Wakui","year":"2008","journal-title":"Int J Hematol"},{"key":"10.1016\/j.clml.2021.03.004_bib0043","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0002-9343(94)90139-2","article-title":"Acute myeloid leukemia in patients more than 50 years of age: special considerations in diagnosis, treatment, and prognosis","volume":"96","author":"Auerbach","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.clml.2021.03.004_bib0044","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12185-012-1150-6","article-title":"Clinical studies of acute myeloid leukemia in the Japan Adult Leukemia Study Group","volume":"96","author":"Miyawaki","year":"2012","journal-title":"Int J Hematol"},{"key":"10.1016\/j.clml.2021.03.004_bib0045","first-page":"111","article-title":"End-of-life characteristics and palliative care provision for elderly patients suffering from acute myeloid leukemia","volume":"23","author":"Cheng","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clml.2021.03.004_bib0046","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s00277-012-1487-1","article-title":"Intensive chemotherapy for elderly patients with acute myelogeneous leukemia: a propensity score analysis by the Japan Hematology and Oncology Clinical Study Group (J-HOCS)","volume":"91","author":"Oshima","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2021.03.004_bib0047","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cancergencyto.2005.03.011","article-title":"Mutations of the FLT3 gene in adult acute myeloid leukemia: determination of incidence and identification of a novel mutation in a Thai population","volume":"162","author":"Auewarakul","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.clml.2021.03.004_bib0048","first-page":"413","article-title":"Mutation analysis of isocitrate dehydrogenase (IDH1\/2) and DNA methyltransferase 3A (DNMT3A) in Thai patients with newly diagnosed acute myeloid leukemia","volume":"18","author":"Sirirat","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.clml.2021.03.004_bib0049","first-page":"675","article-title":"Mutations of AML1 in non-M0 acute myeloid leukemia: six novel mutations and a high incidence of cooperative events in a South-east Asian population","volume":"91","author":"Auewarakul","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2021.03.004_bib0050","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00277-016-2691-1","article-title":"Cytogenetic profiles of 2806 patients with acute myeloid leukemia-a retrospective multicenter nationwide study","volume":"95","author":"Byun","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2021.03.004_bib0051","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0165-4608(81)90025-X","article-title":"Cytogenetic studies in adult acute leukemias","volume":"4","author":"Takeuchi","year":"1981","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.clml.2021.03.004_bib0052","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00277-005-0039-3","article-title":"C-kit receptor tyrosine kinase (CD117) expression and its positive predictive value for the diagnosis of Thai adult acute myeloid leukemia","volume":"85","author":"Auewarakul","year":"2006","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2021.03.004_bib0053","first-page":"1058","article-title":"[Characteristics and treatment outcomes in 822 adult patients with acute myeloid leukemia: a single center experience]","volume":"35","author":"Lin","year":"2014","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.clml.2021.03.004_bib0054","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1600-0609.2006.00663.x","article-title":"Frequency of RAS gene mutation and its cooperative genetic events in Southeast Asian adult acute myeloid leukemia","volume":"77","author":"Auewarakul","year":"2006","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2021.03.004_bib0055","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s12185-012-1146-2","article-title":"Acute myeloid leukemia in clinical practice: a retrospective population-based cohort study in Miyazaki Prefecture","volume":"96","author":"Matsunaga","year":"2012","journal-title":"Int J Hematol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265021001075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265021001075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:36:02Z","timestamp":1761870962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265021001075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":55,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2152265021001075"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2021.03.004","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Types, Clinical Features, and Survival Outcomes of Patients with Acute Myeloid Leukemia in Thailand: A 3-Year Prospective Multicenter Study from the Thai Acute Leukemia Study Group (TALSG)","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2021.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}